Molecular Diagnostics
Novel Protein Biomarkers Identified for Prostate Cancer Aggressiveness
Prostate cancer is the most commonly diagnosed cancer in men and is among the top five causes of cancer-related death. In most cases, prostate cancer can be successfully treated but there is a group of patients who suffer an aggressive course and often fatal outcome. More...05 Jan 2022
Menstrual Blood Testing With Capture Sequencing Detects High-Risk Human Papillomavirus
Persistent infection of high-risk human papillomavirus (hrHPV) is associated with various HPV-related pre-cancers and cancers. In recent years, HPV testing has gradually become the primary method for cervical cancer screening. More...04 Jan 2022
Sex Hormone–Binding Globulin Is a Biomarker for Cardiovascular Disease Risk Independent of Total Testosterone Concentration
The blood protein sex hormone–binding globulin (SHBG) has been shown to be a biomarker that predicts greater risk of myocardial infarction and lower risk of ischemic stroke and heart failure in men between the ages of 40 and 69. More...03 Jan 2022
Parkinson’s Disease Patients Have More Inflammatory Bacteria in Their Noses
Parkinson’s disease (PD) is a complex neurodegenerative disease characterized by nigrostriatal degeneration resulting in bradykinesia, rigidity, tremor, and gait dysfunction. Non-motor symptoms are also typically present, including depression, constipation, and alteration of smell. Diminished sense of smell (hyposmia), is a common hallmark of prodromal PD. More...29 Dec 2021
Certain Protein Ectodomains in Cerebrospinal Fluid Are Diagnostic Biomarkers for Autism
Abnormally low levels of a protein biomarker, which can be detected in the cerebrospinal fluid (CSF), have the potential to be the basis for diagnosis of autism and related neurological disorders. More...27 Dec 2021
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Sample Transportation System
Tempus1800 Necto
Human Estradiol Assay
Human Estradiol CLIA Kit
In Other News
Bacterial Communities Diverge in The Lower Airways of CF Children
Intratumor Heterogeneity Analyzed in Neuroblastoma
Epigenetic Biomarkers for Early Rheumatoid Arthritis Detection
Genomic Screening Can Identify Risk for Amyloid Cardiomyopathy
Cheek Swab Test Could Identify Biomarkers for Rheumatoid Arthritis
Rapid Biopsy Approach Shortens Time Required to Diagnose HPV-linked Head and Neck Cancers
Targeted RNA-Sequencing Panel Detects Gene Fusions in Solid Tumors
A Device for Rapid and Accurate Diagnosis of Hepatitis C Infections
Biomarker Predicts Potential Benefit of Checkpoint Inhibitor Therapy for Brain Cancer Patients
Same Day Test Identifies Secondary Infections in COVID-19 Patients
A Rapid and Sensitive Lateral Flow Test for Diagnosis of Schistosomiasis
First One-Hour, Direct-from-Blood Sepsis Test Receives FDA Clearance
Liquid Biopsy Predicts Therapy Response in Patients with Late-Stage Throat Cancer
Serum MicroRNA Panel Predict P-Tau/Aβ42 in CSF in Alzheimer's Disease
Biomarkers Predict Disease Progression for Patients with Late-stage Brain Tumors
Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021
Blood and Saliva Samples Can Be Used to Detect Genetic Markers for Liver Cancer
Next-Generation Sequencing Impacts All Aspects of Myelodysplastic Syndrome Care
Simple Urine Test Detects Urothelial Cancers in Lynch Syndrome Patients
Same Day DNA Sequencing-Based Test Identifies Secondary Infections in COVID-19 Patients
AI Combined with Genomic Surveillance Beats Humans at Detecting Infectious Disease Outbreaks in Hospital Settings
Novel Protein Biomarkers Linked to Risk of Developing Type I Diabetes
Next-Generation Sequencing Strategy Validated for MRD Monitoring in Multiple Myeloma
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.